MHRA Guidance

SaMD classification, regulatory strategy, and MHRA pathway advisory for digital health products navigating the UK medical device landscape.

What's included

4-6

weeks typical time from intake to regulatory strategy document

UK + UKCA full post-Brexit regulatory framework covered

tHE PROBLEM

The problem with misreading your regulatory status

Since Brexit, the UK operates its own medical device regulatory framework under the MHRA — separate from the EU MDR. For digital health founders, the critical question is whether your product qualifies as a Software as a Medical Device. Getting that classification wrong in either direction is costly.

Overclaiming SaMD status triggers regulatory requirements your product and team are not ready for. Underclaiming it; assuming you are outside scope when you are not, exposes you to enforcement action, procurement rejection, and investor due diligence failures. Neither outcome is recoverable cheaply.

Most teams make this call based on incomplete information, founder intuition, or generic online guidance that does not account for the nuances of their specific product and intended use.

Our standard
Mapped from currentDefinitive SaMD classification based on your actual product processes
Full MHRA regulatory pathway mapped before you commit
Evidence strategy designed around your commercial timeline
Written regulatory position statement included

Deliverables

What's included

01
Strategy

Product review and SaMD classification before any regulatory pathway is committed to.

02
Build

Full regulatory strategy document and MHRA pathway plan.

03
Handoff

Submission preparation and pre-filing documentation package.

04
Support

Ongoing regulatory advisory as your product evolves and submissions progress.

How we work

A process built for results

Clear milestones, expert-led accountability, and no regulatory surprises. Here’s how we get from intake to a confirmed pathway.

Step 01
Discovery & Classification

We review your product’s intended use, clinical function, and user population to determine definitive SaMD classification under MHRA rules.

Step 02
Pathway Mapping

We map your full regulatory pathway — registration requirements, technical file obligations, conformity assessment route, and UKCA marking strategy.

Step 03
Evidence & Documentation Strategy

We design your evidence generation plan and build the pre-submission documentation your pathway requires.

Step 04
Submit + Ongoing Advisory

We support MHRA interactions, respond to queries, and provide ongoing regulatory advisory as your product develops

Our stack

MHRA advisory examples

See what's possible

STARTUP
CLASSIFICATION
SaMD Classification Review
INPUTS
New digital health product pre-build
ACTION
Intended Use
Classification
Pathway Map
RESULT
SCALE-UP
STRATEGY
Regulatory Strategy Document
INPUTS
Product post-build seeking MHRA route
ACTION
Review
Classify
Evidence Plan
Written Strategy
RESULT
ENTERPRISE
DUE DILIGENCE
Regulatory Due Diligence Support
INPUTS
Investor or acquirer requesting regulatory position
ACTION
Audit
Position Statement
Investor Pack
RESULT

What clients say

FAQ

Common questions

Everything you need to know before we start working together.

It depends on the scope. A DTAC self-assessment support engagement typically runs 4–6 weeks. A full DCB0129 clinical safety documentation package is usually 6–10 weeks. Ongoing CSO support is structured as a monthly retainer with no fixed end date. We scope every engagement at the discovery call so you know exactly what to expect before we start.

Yes — and it’s where early investment in compliance pays off most. Many founders wait until a procurement opportunity arises before addressing regulatory requirements, which costs time and deals. We help early-stage teams build the right foundations from the start so compliance becomes a commercial asset, not a last-minute hurdle.

Yes. We support teams through NHS and ICB procurement processes including tender preparation, compliance evidence mapping, and DTAC submission. We understand what commissioners look for and how to structure evidence to meet those expectations.

DCB0129 is the NHS clinical risk management standard for health IT systems. If your product is used in a clinical setting, interfaces with patient data, or is being procured by an NHS organisation, you almost certainly need it. It requires a documented clinical safety case, a hazard log, and sign-off by a qualified Clinical Safety Officer. We handle all of this.

Yes. We advise international digital health companies seeking to enter the UK market — covering regulatory positioning, DTAC readiness, NHS procurement strategy, and clinical safety requirements. We also support GCC-based health technology investors and health system buyers navigating the UK digital health landscape.

Within one business day of your call, we send a written summary of your regulatory position and a proposed engagement scope. If you are ready to proceed, we issue a fixed-scope agreement and begin onboarding. There is no obligation after the discovery call; it is purely a diagnostic conversation..

Yes. We regularly step into engagements mid-stream; reviewing existing hazard logs, safety cases, DTAC evidence packs, and regulatory submissions. We identify gaps, correct errors, and get your documentation to a standard that holds up under scrutiny. You do not need to start from scratch to work with us.

GET STARTED

Let's talk about your compliance

Book a discovery call or send us a message. We’ll get back to you.

30 minutes to map your regulatory position. No pitch, no pressure; just a focused conversation about your digital health challenge.

Schedule a discovery call

Tell us about your product, regulatory position, or advisory need.

We'll only use your info to respond to your inquiry.